載入...
Eribulin mesylate (halichondrin B Analog E7389) in platinum-resistant and platinum-sensitive ovarian cancer: a two-cohort, phase II study
BACKGROUND: Eribulin mesylate is a tubulin inhibitor with activity superior to paclitaxel in NIH:OVCAR-3 human epithelial ovarian cancer xenograft models. We sought to assess the efficacy of eribulin in platinum-resistant and platinum-sensitive recurrent ovarian cancer. METHODS: Patients with recurr...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
2011
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3245795/ https://ncbi.nlm.nih.gov/pubmed/21935916 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26569 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|